Address
Email address
Phone number
https://bioconcept.euBioconcept BalticsBioconcept Baltics deals with Wholesale and distribution of sex products in Europe.
Name
Bioconcept Baltics OÜ
Registry code
11086967
VAT number
EE100941823
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
01.12.2004 (19)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
46901 - Non-specialised wholesale trade 46461 - Wholesale of medicines and other pharmacy goods
790 426 €
91 032 €
12%
-
519 434 €
1
Submitted
No tax arrears
18%
16%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Jan Sören Larsson 01.03.1967 (57) | 100% - 2 556.00 EUR | Board member | Direct ownership | |
| OÜ Ermitex Investeeringud 10616506 | - | - | - | Founder |
| 2019 06.10.2020 | 2020 29.06.2021 | 2021 30.06.2022 | 2022 30.06.2023 | 2023 28.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 376 366 € | 449 620 € | 522 762 € | 787 149 € | 790 426 € |
| Net profit (loss) for the period | 45 967 € | 70 415 € | 84 720 € | 155 340 € | 91 032 € |
| Profit Margin | 12% | 16% | 16% | 20% | 12% |
| Current Assets | 300 316 € | 359 078 € | 388 273 € | 495 879 € | 566 378 € |
| Fixed Assets | 1 090 € | 0 € | - | - | - |
| Total Assets | 301 406 € | 359 078 € | 388 273 € | 495 879 € | 566 378 € |
| Current Liabilities | 47 788 € | 55 279 € | 59 832 € | 28 227 € | 46 944 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 253 618 € | 303 799 € | 328 441 € | 467 652 € | 519 434 € |
| Employees | 1 | 1 | 1 | 1 | 1 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 234 905.28 € | 12 714.41 € | 994.64 € | - |
| 2023 Q4 | 226 962.53 € | 11 362.27 € | 610.5 € | - |
| 2023 Q3 | 327 913.37 € | 15 086.13 € | 241.95 € | - |
| 2023 Q2 | 277 323.5 € | 25 154.76 € | 2 123.67 € | - |
| 2023 Q1 | 437 499.27 € | 30 778.38 € | 241.95 € | - |
| 2022 Q4 | 439 075.47 € | 26 585.56 € | 1 817.24 € | - |
| 2022 Q3 | 183 173.88 € | 9 356.66 € | 2 116.08 € | - |
| 2022 Q2 | 135 299.9 € | 9 220.24 € | 2 116.08 € | 1 |
| 2022 Q1 | 134 728.91 € | 14 165.58 € | 3 103.66 € | 1 |
| 2021 Q4 | 190 997.98 € | 14 750.23 € | 2 005.89 € | 1 |
| 2021 Q3 | 111 231.34 € | 9 432.42 € | 1 364.22 € | 1 |
| 2021 Q2 | 144 459.09 € | 13 753.74 € | 241.95 € | 1 |
| 2021 Q1 | 131 747.48 € | 11 358.89 € | 947.39 € | - |
| 2020 Q4 | 169 266.1 € | 6 555.3 € | 246.16 € | - |
| 2020 Q3 | 135 002.04 € | 7 407.85 € | 241.95 € | - |
| 2020 Q2 | 110 207.68 € | 7 021.03 € | 475.28 € | - |
| 2020 Q1 | 100 876.1 € | 4 534.66 € | 609.43 € | - |
